Cell signaling news
Here we present recent news items specially selected from Nature, Nature Medicine and Nature Biotechnology.
March 2006
2006:
December |
November |
October |
September |
August |
July |
June |
May |
April |
March |
February |
January
Other years: 2002 | 2003 | 2004 | 2005 | 2007 | 2008
News | News in brief | News Features
News
Stem cells from testes:could it work?
Researchers at the Georg August University of Göttingen in Germany announced they had found a source of reprogrammable cells in the testes of adult mice.
Nature (30 March 2006)
| Full Text |
US to rule on research patent
Before the US Supreme Court adjourns at the end of June, it may decide whether a patent based on a biological relationship between two substances can be issued.
Nature (30 March 2006)
| Full Text |
London's disastrous drug trial has serious side effects for research
A drug trial that took a shocking turn in London last week may have far-reaching effects on policy.
Nature (24 March 2006)
| Full Text |
Trauma trials leave ethicists uneasy
A US trial of an experimental blood substitute given to trauma patients who cannot give consent is stirring concern about the way that such 'no consent' trials are run.
Nature (24 March 2006)
| Full Text |
Huge Biobank project launches despite critics
British family doctors have started recruiting subjects for an ambitious effort to probe the interplay of genetic and environmental factors that cause disease.
Nature (16 March 2006)
| Full Text |
Saving Italian science
As the general election looms, candidate prime minister Romano Prodi strives to convince Italy's discontented scientists that he can turn things around.
Nature (16 March 2006)
| Full Text |
Ukraine scientists grow impatient for change
Scientists are increasingly frustrated by the slow pace of reform of the country's Soviet-style research system.
Nature (09 March 2006)
| Full Text |
Can cats spread avian flu?
Felines are fast becoming a new focus for fears over avian flu, as cats infected with the deadly H5N1 strain are reported in Austria, Germany, Thailand and Indonesia.
Nature (09 March 2006)
| Full Text |
One year after launch, drug safety board is dubbed a failure
A new drug safety board at the US Food and Drug Administration (FDA) is failing in its declared goal of increasing openness and transparency at the agency, critics say.
Nature Medicine (March 2006)
| Full Text |
After criticism, more modest cancer genome project takes shape
A project to identify the genetic changes that cause cancer, dubbed The Cancer Genome Atlas, will begin with a $100 million pilot project, but could expand to $1 billion or more over the next decade.
Nature Medicine (March 2006)
| Full Text |
Biomedical research faces bleak budgets
NIH's budget remains flat for the fourth straight year as the gap between spending on research in defense- and non-defense-related areas widens.
Nature Medicine (March 2006)
| Full Text |
Gene therapy finds welcoming environment in China
The recent approval of two drugs based on gene therapy, have fueled quick growth in the field, but they may be a sign that China's drug regulation is too lax, experts caution.
Nature (March 2006)
| Full Text |
Toll-like receptor therapies compete to reduce side effects
An emerging class of highly specific immunomodulator drugs targeting toll-like receptors will be the focus of attention this month at a conference in Salvador, Brazil.
Nature Biotechnology (March 2006)
| Full Text |
Bets are placed for next Harvard president
Summers's announcement on 21 February that he will step down in June marked the climax of a year of intense criticism from academics unhappy with his brusque leadership and lack of consultation with faculty.
Nature (02 March 2006)
| Full Text |
Scepticism greets EU plan for virtual institute
Plans announced last week to create a European Institute of Technology (EIT) have received a lukewarm reception from the scientific community.
Nature (02 March 2006)
| Full Text |
Rules tighten for stem-cell studies
New guidelines aim to promote international collaborations in a field badly shaken by the South Korean cloning scandal.
Nature (02 March 2006)
| Full Text |
Demo backs animal lab in Oxford
Hundreds of scientists and students took to the streets of Oxford last weekend to march in favor of the city's new biomedical lab.
Nature (02 March 2006)
| Full Text |
News in brief
New York universities get $400-million hand-out
| Punchy plan gives Japan's scientists explicit targets
| Pakistan aims to build six science universities
| Board of Canadian journal sides with sacked editors
| Science committee chair makes retirement plan
| Retraction costs Hwang his licence and his job
| Biologists appeal to Senate to safeguard species act
| US drug agency looks set to get permanent leader
| Plant biologist named as Australia's science adviser
| EMBO helps life scientists set up labs in Europe
| Japanese researcher finds synthetic route to Tamiflu
| Institute that cloned Dolly heads for pastures new
| New program gives postdocs a leg up
| Biologists' secrecy said to stall science
| USDA approves the first plant-based vaccine
| Prizewinning stem cells take Australian grand tour
| Licensing thumbs-down for drug from GM goats
News Features
Mitochondrial disease: Powerhouse of disease
Many of the genes affecting mitochondria reside in the cell nucleus. Nick Lane joins the hunt for these sequences that may underpin diseases such as diabetes.
Nature (30 March 2006)
| Full Text |
Too little, too late?
Germany's once powerful pharmaceutical industry is now heavily fragmented. But the company that produced the world's first blockbuster drug is making a bid to reclaim some lost ground.
Nature (30 March 2006)
| Full Text |
2020 computing: Everything, everywhere
Tiny computers that constantly monitor ecosystems, buildings and even human bodies could turn science on its head.
Nature (24 March 2006)
| Full Text |
Drive for drugs leads to baby clinical trials
Earlier this year the US Food and Drug Administration (FDA) announced new rules that will allow small doses of experimental drugs to be tested in people before full-scale clinical trials begin.
Nature (24 March 2006)
| Full Text |
Drug trials: Stacking the deck
Studies of medical literature are confirming what many suspected — reporters of clinical trials do not always play straight.
Nature (16 March 2006)
| Full Text |
Political chemistry: Make a strong bond
Roald Hoffmann, a Nobel laureate from Cornell University, has organized a series of chemistry workshops for young scientists from the Middle East, with the aim of forging trust and friendship between participants.
Nature (16 March 2006)
| Full Text |
Monkey business
China is preparing to become the world's supplier of research primates. But are Western scientists ready to buy?
Nature Medicine (March 2006)
| Full Text |
Finding the moral high ground
Biotech companies will be facing particular ethical challenges as their products enter the marketplace, but how is the industry preparing?
Nature Biotechnology (March 2006)
| Full Text |
Where the money is
It was US investors that largely bankrolled the biotech industry over the past 25 years, will this be the case over the next decade?
Nature Biotechnology (March 2006)
| Full Text |
Molecular microscopy: Focus on the living
Atomic force microscopes have revolutionized the study of materials, but probing watery biological systems has proved more difficult, until now.
Nature (02 March 2006)
| Full Text |
After-school programmes
PhD students, postdocs and even senior scientists are taking continuing-education courses to improve their scientific 'hard skills' or branch out beyond the lab.
Nature (02 March 2006)
| Full Text |
|
